Mestanza-Peralta M., Ariza-Ariza R., Cardiel MH, Alcocer-Varela J.Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol1997; 24: 867-870.
2.
Miller MH, Urowitz MB, Gladman DDThe significance of thrombocytopenia in systemic lupus erythematosus . Arthritis Rheum1983; 26: 1181-1186.
3.
Gunnarsson I. , Sundelin B., Jonsdottir T., Jacobson SH, Henriksson EW, van Vollenhoven RFHistopathologic and clinical outcome of Rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis Rheum2007; 56: 1263-1272.
4.
Perrotta S., Locatelli F., La Manna A., Cennamo L., De Stefano P., Nobili B.Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol2002; 116: 465-467.
5.
Lindholm C., Borjesson-Asp K., Zendjanchi K., Sundqvist AC, Tarkowski A., Bokarewa M.Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol2008; 35: 826-833.
6.
Lehembre S., Macario-Barrel A., Musette P., Carvalho P., Joly P.Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus. Ann Dermatol Venereol2006; 133: 53-55.
